Cost-effectiveness of dabigatran and rivaroxaban compared with warfarin for stroke prevention in patients with atrial fibrillation

Y Wang, F Xie, MC Kong, LH Lee, HJ Ng… - Cardiovascular drugs and …, 2014 - Springer
Purpose This study aimed to evaluate the cost-effectiveness of dabigatran and rivaroxaban
compared with warfarin for the prevention of stroke in patients with atrial fibrillation (AF) in …
被引用次数：28 相关文章

Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation.

Y Wang, F Xie, M Kong, L Lee… - Cardiovascular Drugs & …, 2014 - search.ebscohost.com
Purpose: This study aimed to evaluate the cost-effectiveness of dabigatran and rivaroxaban
compared with warfarin for the prevention of stroke in patients with atrial fibrillation (AF) in …

Cost-effectiveness of dabigatran and rivaroxaban compared with warfarin for stroke prevention in patients with atrial fibrillation.

Y Wang, F Xie, MC Kong, LH Lee, HJ Ng… - … Drugs and Therapy, 2014 - europepmc.org
This study aimed to evaluate the cost-effectiveness of dabigatran and rivaroxaban compared
with warfarin for the prevention of stroke in patients with atrial fibrillation (AF) in Singapore. A …

Cost-effectiveness of dabigatran and rivaroxaban compared with warfarin for stroke prevention in patients with atrial fibrillation

Y Wang, F Xie, MC Kong, LH Lee… - … drugs and therapy, 2014 - pubmed.ncbi.nlm.nih.gov
Purpose This study aimed to evaluate the cost-effectiveness of dabigatran and rivaroxaban
compared with warfarin for the prevention of stroke in patients with atrial fibrillation (AF) in …

Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation

Y Wang, F Xie, MC Kong, LH Lee… - … Drugs and Therapy, 2014 - search.proquest.com
Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention
in Patients with Atrial Fibrillati Page 1 ORIGINAL ARTICLE Cost-effectiveness of Dabigatran and …

[引用][C] Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation

YE WANG, F XIE, MC KONG, LAIH LEE… - … drugs and therapy, 2014 - pascal-francis.inist.fr
Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke
Prevention in Patients with Atrial Fibrillation CNRS Inist Pascal-Francis CNRS Pascal and …

Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation

Y Wang, F Xie, MC Kong, LH Lee, HJ Ng… - … Drugs and Therapy, 2014 - hub.tmu.edu.tw
Purpose: This study aimed to evaluate the cost-effectiveness of dabigatran and rivaroxaban
compared with warfarin for the prevention of stroke in patients with atrial fibrillation (AF) in …

Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation

Y Wang, F Xie, MC Kong, LH Lee, HJ Ng… - Cardiovascular Drugs and …, 2014 - infona.pl
Purpose This study aimed to evaluate the cost-effectiveness of dabigatran and rivaroxaban
compared with warfarin for the prevention of stroke in patients with atrial fibrillation (AF) in …

Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation

Y Wang, F Xie, MC Kong, LH Lee, HJ Ng… - … Drugs and Therapy, 2014 - hub.tmu.edu.tw
Purpose: This study aimed to evaluate the cost-effectiveness of dabigatran and rivaroxaban
compared with warfarin for the prevention of stroke in patients with atrial fibrillation (AF) in …

[引用][C] Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation

YE WANG, F XIE, MC KONG, LAIH LEE… - … drugs and therapy, 2014 - Springer